Avoiding 483 Observations and Warning Letters 2012 is a webinar that covers topics such as:
Avoiding 483 Observations and Warning Letters 2012 brings together QA, Senior management in Drugs, Devices, Biologics, Dietary Supplements, R&D, RA, Production, Engineering, Consultants others tasked with product, process, validations, cGMP responsibilities and Operations.